FDA Inspection 550884 — NYU Langone Health, Transplantation & Cellular Therapy

NYU Langone Health, Transplantation & Cellular Therapy — FEI 2470026

The FDA completed an inspection of NYU Langone Health, Transplantation & Cellular Therapy on December 19, 2008 in New York, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 19, 2008
Fiscal Year
2009
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New York, NY (United States)

Citations

IDCFRDescription
20821 CFR 640.3(a)(1)Donor suitability procedures not followed
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs